Eligible subjects who have signed a consent form will be asked to wear the Alio device at specified location(s) for up to four regularly scheduled dialysis sessions. The device will be placed and worn throughout the entire session.
Subjects will have blood draws that will be used to compare to device metrics. Additional vitals and monitoring may happen throughout this study.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 and older
maintenance dialysis for ESRD via AVF/AVG in an arm location for at least 6 months
written informed consent
able to wear the SmartPatch as instructed and follow study protocols
You may not be if
Skin near the proximity of Patch placement is swollen, infected and/or inflamed
pregnancy
serious medical condition which in the opinion of the investigator may adversely affect the safety of the subject or the device being evaluated
AVF/AVG in a non-arm location
participants with novel indications for their AVG (ie. HeRO grafts)
participation in any other clinical trials that could affect the quality of study data
Clareo Health | The Jordan Study for End-Stage Renal Disease Subjects
